ICM
ABBV icon

Ionic Capital Management’s AbbVie ABBV Stock Holding History

Ionic Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,200
Closed -$265K – 342
2016
Q3 		$265K Buy
+4,200
New +$272K 0.01% 320
2014
Q4 		– Sell
-196,600
Closed -$11.4M – 274
2014
Q3 		$11.4M Buy
+196,600
New +$10.9M 0.36% 65

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ionic Capital Management's ABBV Position: Q4 2016 in Review

Ionic Capital Management sold out of AbbVie (ABBV) in Q4 2016, closing a stake of 4,200 shares — an estimated $265K sold.

Ionic Capital Management first reported a position in ABBV in Q3 2014 and held it in 2 quarters. The position peaked at $11.4M in Q3 2014. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • Ionic Capital Management reported no remaining AbbVie position as of Q4 2016 after selling out during the quarter.
  • Ionic Capital Management sold 4,200 AbbVie shares in Q4 2016, an estimated $265K.
  • Ionic Capital Management first reported a position in AbbVie in Q3 2014 and held it in 2 quarters.
  • Ionic Capital Management's AbbVie position peaked at $11.4M in Q3 2014.
  • 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on Ionic Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.